Kyverna Therapeutics, Inc. (KYTX)
9.18
+0.09
(+0.99%)
USD |
NASDAQ |
Mar 17, 09:48
Kyverna Therapeutics Market Cap : 402.05M for March 17, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.622B |
| CorMedix, Inc. | 522.92M |
| Castle Biosciences, Inc. | 777.17M |
| EyePoint Plc | 1.146B |
| Vistagen Therapeutics, Inc. | 24.92M |
Market Cap Related Metrics
| PEG Ratio | -0.1162 |
| Price to Book Value | 2.646 |
| Price | 9.18 |
| Earnings Yield | -40.53% |
| PEGY Ratio | -0.1162 |